Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-25 @ 3:20 PM
NCT ID:
NCT05212168
Pre Assignment Details:
Healthy participants were randomized in a 1:1 ratio to receive a single oral dose of VXA-G1.1-NN or placebo. The total study duration for each participant was approximately 16 months, including screening, a 28-day vaccination phase, a 28-day Challenge Phase, and up to 365 days of safety follow-up.
Recruitment Details:
Participants were enrolled at 1 center in the United States (US) between December 2021 and October 2023.
Study:
NCT05212168
Study Brief:
Results Section:
NCT05212168